Approach
Our approach balances affinity and avidity to generate novel immunotherapies that will enable durable patient responses.
![circle-sci-2](https://www.linkimmunotherapeutics.com/wp-content/uploads/2021/10/circle-sci-2.png)
Empirical
We are intentional and unrelenting in our focus on rigorous science and verifiable observations.
![circle-sci-2](https://www.linkimmunotherapeutics.com/wp-content/uploads/2021/10/circle-sci-2.png)
![IgG_purple](https://www.linkimmunotherapeutics.com/wp-content/uploads/2021/10/IgG_purple.png)
Intentional
We select validated cancer targets and novel target combinations to build on existing knowledge in creating better molecules.
Best
Through rigorous science and full-on dedication, we are building best-in-class and first-in-class therapeutics.